Table 4.
Results of concordance analysis between the two liver protocols for the detection of suspicious findings.
| Suspicious findings | No. of concordant pairs | No. of discordant pairs |
|---|---|---|
| Cysts | 32 | 1 |
| Metastasis | 23 | 2 |
| Splenomegaly | 7 | 0 |
| Transient hepatic intensity difference | 6 | 1 |
| Tumor embolus | 6 | 0 |
| Cirrhosis | 5 | 0 |
| Cholecystolithiasis | 5 | 0 |
| Ascites | 5 | 0 |
| Hemangioma | 4 | 0 |
| Lymph node enlargement | 3 | 0 |
| hepatocellular carcinoma (HCC) | 3 | 0 |
| Viable residual tumor tissue of HCC after treatment | 3 | 1 |
| Viable residual tumor tissue of liver metastasis after treatment | 2 | 0 |
| Nodule | 2 | 0 |
| Pneumonia | 2 | 0 |
| Fatty liver | 2 | 0 |
| Chronic cholecystitis | 2 | 0 |
| Cholecystitis | 2 | 0 |
| Bile ducts dilation | 2 | 0 |
| Others* | 18 | 0 |
| Total | 134 | 5 |
| Percentage | 96.40% | 3.60% |
*Others include those findings found in only one case. These include adenomyomatosis, atelectasis, cortical adenoma, esophageal-gastric varices, gallbladder enlargement, gastric antrum cancer, gastric retention, hydronephrosis, hydrothorax, hydroureterosis, infarction, pancreatic atrophy, portal, hypertension, renal atrophy, splenculus, thrombus, unviable post-treatment tumor tissue, and vascular malformation.